Loading organizations...
§ Venture Capital · Shanghai, Shanghai, China
Shanghai Zhangjiang Healthcare Venture Capital Partnership LP operates as a specialized venture capital firm, investing primarily in the healthcare sector. It provides growth capital to innovative enterprises within the life sciences, focusing on biotechnology, biopharmaceuticals, and medical devices. The firm's approach identifies and supports companies poised to advance critical healthcare technologies and services.
Established in March 2021, this partnership emerged from Shanghai's dynamic Zhangjiang Science City life sciences hub. Its formation reflects a strategic commitment to leverage the region's robust research infrastructure and talent. The firm's inception stemmed from the insight that focused capital is crucial for transforming scientific breakthroughs into viable commercial healthcare applications.
The firm primarily serves early to mid-stage healthcare companies seeking funding for research, development, and market entry. Shanghai Zhangjiang Healthcare Venture Capital Partnership LP envisions itself as a pivotal force in strengthening the domestic healthcare industry. Its long-term objective is to contribute to global health by fostering companies delivering transformative medical innovations and improving patient outcomes.
Zhangjiang Healthcare Venture Capital has 1 tracked investment across 1 company. The latest tracked deal is $25.2M Series B in Eccogene in June 2023.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jun 12, 2023 | Eccogene | $25.2M Series B | NEW Alliance Capital, Zhangjiang Healthcare Venture Capital | Delos Capital, Rockbleu Capital, Yufu Investment |